Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials

Variants in CYP2D6 and CYP2C19 have already adequate support for clinical application. The development of future PGx tests should include best practices for clinical evidence development and for health economic assessment.